Beginning the first week of September, The National Institutes of Health will sponsor the first human trials of an Ebola vaccine. 

NIAID and GlaxoSmithKline are developing the vaccine, which has been shown to protect monkeys against Ebola.

Read the full article here: http://www.nbcnews.com/storyline/ebola-virus-outbreak/first-human-trials-ebola-vaccine-start-next-week-n190716